Godavari Drugs Ltd.
Fundamentals
- Market cap
- ₹122 cr
- P/E
- 29.85×
- ROE
- 10.10%
- Debt / equity
- 1.48
- 52-week range
- 69.70 — 135.25
Company snapshot
Godavari Drugs Ltd.
Pharmaceuticals
₹123 cr
P/E 29.98×
Latest quarter · Mar 2026
Sales₹33 cr
Net profit₹1 cr
Op. margin+8.9%
EPS₹1.27
Strength & growth
Debt / equity1.48×
Current ratio1.08×
Sales CAGR+3.7%
EPS CAGR+8.3%
The timeline — 2 notes on Godavari Drugs Ltd.
May 2026
- 27 May 26 · 5:02 PM IST Brief Brief · Earnings · Micro cap
Godavari Drugs revenue slips to ₹105.81 cr in FY26
The nano-cap pharmaceutical firm reported a modest annual decline in both revenue and profit, though Q4 showed sequential growth.
- 27 May 26 · 4:57 PM IST Brief Brief · Earnings · Micro cap
Godavari Drugs reports flat FY26 results as revenue slips to ₹105.81 cr
The nano-cap pharmaceutical company saw annual revenue and profit decline slightly, though Q4 standalone revenue showed improvement.